Determinants of right ventricular ejection fraction in pulmonary arterial hypertension

Chest

Volumn 135, Issue 3, 2009, Pages 752-759

  Kawat, Steven M ^a,d   Al Namnani, Nadine ^a   Agerstrand, Cara ^a   Rosenzweig, Erika Berman ^b   Rowan, Cherise ^b   Barst, Rohyn J ^b   Bergmann, Steven ^c   Horn, Evelyn M ^a  

^a Department of Medicine and Pediatrics ^*  (United States)

^b Columbia University ^*  (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypertension; Pulmonary; Right ventricle; Von willebrand factor

Indexed keywords

ANOREXIGENIC AGENT; VON WILLEBRAND FACTOR;

ADULT; AGING; ARTICLE; CORRELATION ANALYSIS; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SCINTIANGIOGRAPHY; SEX DIFFERENCE;

EID: 62149097543     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1758     Document Type: Article

References (43)

1. McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126:78S-92S
2. Chen EP, Craig DM, Bittner HB, et al. Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation 1998; 97:1606-1612
3. Szabo G, Soos P, Bahrle S, et al. Adaptation of the right ventricle to an increased afterload in the chronically volume overloaded heart. Ann Thorac Surg 2006; 82:989-995
4. Sandoval J, Bauerle O, Palomar A, et al. Survival in primary pulmonary hypertension: validation of a prognostic equation. Circulation 1994; 89:1733-1744
5. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28:1250-1257
6. D Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-349
7. Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95:199-203
8. Quaife RA, Chen MY, Lynch D, et al. Importance of right: ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress. Eur J Med Res 2006; 11:214-220
9. de Groote P, Millaire A, Foucher-Hossein C, et al. Right: ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998; 32:948-954
10. Di Salvo TG, Mathier M. Semigran MJ, et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995; 25:1143-1153
11. Voelkel NF, Quaife RA. Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114:1883-1891
12. Haddad F, Doyle R, Murphy DJ, et al. Right ventricular function in cardiovascular disease: Part II. Pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117:1717-1731
13. Haddad F, Hunt SA, Rosenthal DN, et al. Right ventricular function in cardiovascular disease: Part 1. Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008; 117:1436-1448
14. Nichols K, Saouaf R, Ababneh aa, et al. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging. J Nucl Cardiol 2002; 9:153-160
15. Kawut SM, Horn EM, Berekashvili KK, et al. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulm Pharmacol Ther 2006; 19:370-374
16. Kawut SM, Horn EM. Berekashvili KK, et al. von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension. Chest 2005; 128:2355-2362
17. Quaife RA, Lynch D, Badesch DB, et al. Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy. J Card Fail 1999; 5:46-54
18. McCann GP, Gan CT, Beek AM, et al. Extent of MRI delayed enhancement of myocardial mass is related to right: ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol 2007; 188:349-355
19. Kawut SM, Taichman DB, Archer-Chicko CL, et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003; 123:344-350
20. Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006; 54:3043-3050
21. Overbeek MJ, Lankhaar JW, Westerhof N, et al. Different right ventricular contractility in limited cutaneous systemic sclerosis-associated pulmonary arterial Hypertension and idiopathic pulmonary arterial hypertension. Eur Respir J 2008; 31:1160-1166
22. Tandri H, Daya SK, Nasir K, et al. Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol 2006; 98:1660-1664
23. Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation 2007;116:2747-2759
24. De Maria R, Gavazzi A, Recalcati F, et al. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men: the Italian Multicenter Cardiomyopathy Study Group (SPIC). Am J Cardiol 1993; 72:580-585
25. Douglas PS, Kate SK, Weinberg EO, et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 1998; 32:1118-1125
26. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic Hypertension. Am J Cardiol 1993;72:310-313
27. Alia F, Al-Hindi AY, Lee CR, et al. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction. Am Heart J 2007; 153:1074-1080
28. Tamura T, Said S, Gerdes AM. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 1999; 33:676-680
29. Jain M, Liao R, Podesser BK, et al. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol 2002; 283:H2544-H2550
30. Podesser BK, Jain M, Ngoy S, et al. Unveiling gender differences in demand ischemia: a study in a rat model of genetic hypertension. Eur J Cardiothorac Surg 2007; 31:298-304
31. Vitale G, Galderisi M, Colao A, et al. Circulating insulin-like growth factor-I levels are associated with increased biventricular contractility in top level rowers. Clin Endocrinol (Oxf) 2008; 69:231-236
32. Grohe CBG, Stimpel M, Karas RH, et al. Functional estrogen receptors in myocardial and myogenic cells [abstract]. Circulation 1994; 90:528
33. Mahmoodzadeh S, Eder S, Nordmeyer J, et al. Estrogen receptor alpha up-regulation and redistribution in human heart Mure. Faseb J 2006; 20:926-934
34. Mondul AM, Rodriguez C, Jacobs EJ, et al. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005; 162:1089-1097
35. Schocken DD, Arrieta Ml, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20:301-306
36. Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007; 30:1103-1110
37. Loyd JE, Butler MG, Foroud TM, et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am ] Respir Crit Care Med 1995;152:93-97
38. Lankhaar JW, Westerhof N, Faes TJ, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006;291:H1731-H1737
39. Lankhaar JW, Westerhof N, Faes TJ, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008; 29:1688-1695
40. van Wolferen SA, Marcus JT, Westerhof N, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2008; 29:120-127
41. Gomez A, Bialostozky D, Zajarias A, et al. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol 2001; 38:1137-1142
42. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108:626-635
43. Shah SJ, Thenappan T, Rich S, et al. Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. Circulation 2008; 117:2475-2483